Donald Keyser
Voorzitter bij LANTERN PHARMA INC.
Vermogen: 254 497 $ op 31-05-2024
Profiel
Donald Jeffrey Keyser was the founder of ZS Pharma, Inc. (founded in 2008) where he held the title of Chief Operating Officer in 2015.
He is also the founder of Renibus Therapeutics, Inc. (founded in 2015) where he currently holds the titles of President, CEO, CFO, Secretary & Director.
Dr. Keyser's current job is as Chairman at Lantern Pharma, Inc. (since 2018).
Dr. Keyser's former jobs include Senior Director-Regulatory Affairs at Marion Merrell Dow, Inc., Regulatory Principal at Abbott Laboratories, Chief Compliance Officer & VP-Regulatory Affairs at Encysive Pharmaceuticals, Inc. (2004-2008), Vice President-Development & Regulatory Affairs at Adams Respiratory Therapeutics, Inc. (1998-2004), Principal at Marion Laboratories (1985-1991), Vice President-Development & Regulatory Affairs at Adams Laboratories, Inc., and Vice President-Technical & Regulatory Affairs at Medeva Americas, Inc.Dr. Keyser's education includes undergraduate and graduate degrees from Creighton University, a doctorate degree from The University of Texas at Dallas, and a graduate degree from the University of Missouri-Kansas City.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LANTERN PHARMA, INC.
0.39% | 15-04-2024 | 41 927 ( 0.39% ) | 254 497 $ | 31-05-2024 |
Actieve functies van Donald Keyser
| Bedrijven | Functie | Begin |
|---|---|---|
| LANTERN PHARMA INC. | Voorzitter | 01-11-2019 |
Renibus Therapeutics, Inc.
 Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX. | Algemeen Directeur | 21-03-2024 |
Eerdere bekende functies van Donald Keyser
| Bedrijven | Functie | Einde |
|---|---|---|
| ZS PHARMA INC | Oprichter | 01-12-2015 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Compliance Officer | - |
Adams Respiratory Therapeutics, Inc.
 Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Algemeen Adviseur | 01-01-2004 |
| Marion Laboratories | Corporate Officer/Principal | 01-01-1991 |
| Marion Merrell Dow, Inc. | Algemeen Adviseur | - |
Opleiding van Donald Keyser
| Creighton University | Graduate Degree |
| The University of Texas at Dallas | Doctorate Degree |
| University of Missouri-Kansas City | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| LANTERN PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
| Marion Laboratories | Distribution Services |
| Adams Laboratories, Inc. | |
| Medeva Americas, Inc. | |
Renibus Therapeutics, Inc.
Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX. | Health Technology |
